COVID-19 can only gain side the body through the nose but not
through the eyes and mouth
|
|
Incubation Periods for the COVID-19 virus
2-14 days
|
80.2%
|
True |
9.5% |
14-30 days |
18.4% |
False |
90.5% |
Up to 45 days |
1.4% |
Who looks healthy and has no cough or fever cannot spread
COVID-19 |
|
Main methods of transmission of COVID-19 virus |
|
True |
6% |
Raw Food |
7.5% |
False |
94% |
Body Fluids |
26.4% |
|
|
Fecal- Oral Route |
26.4% |
|
|
Air droplets |
64.4% |
|
|
Close contact from person to person
Contaminated surfaces
Coughing and sneezing
|
82.2%
82.5%
89.1%
|
The best way to prevent COVID-19 is to avoid the crowd and
staying at home
|
|
Signs and symptoms associated with COVID-19
Edema
|
2.3%
|
True |
98.9% |
Ageusia |
5.2% |
False |
1.1% |
Insomnia |
19 % |
|
|
CT ground- glass Opacification |
23.3% |
|
|
Anorexia
Diarrhea
|
27.3%
68.1%
|
|
|
General weakness |
91.1% |
|
|
Headache |
91.4% |
|
|
Dry cough |
94.8% |
|
|
Shortness of breath |
95.1% |
|
|
Fever |
96.6% |
According to Sudan case treatment protocol, the management of
mild cases includes
|
|
Risk factors for severe-moderate illness of COVID-19
Adult female
Children
|
4.6%
7.8%
|
Corticosteroids |
2% |
Adult male |
17.8% |
Amoxicillin 500 mg |
9.2% |
Pregnant |
64.4% |
Oxygen |
24.4% |
Smoker |
79.7% |
Azithromycin 500 mg |
67.5% |
Cancer patients |
82.2% |
Vitamin D 1000 IU |
73.0% |
Older Adults |
93.7% |
Vitamin C 1000 IU |
96.8% |
Chronic Diseases |
96% |
According to Sudan case treatment protocol, the management of
moderate cases includes
Corticosteroids
|
8.9%
|
|
|
Amoxicillin 500 mg |
12.6% |
|
|
Oxygen |
55.7% |
|
|
Hydroxy chloroquine 400mg |
75.3% |
|
|
Azithromycin 500 mg |
88.5% |
|
|